Life Sciences: Patent Litigation | Europe

Clifford Chance has a long-established reputation as a market-leading IP practice in Spain. It benefits from the presence both of hugely respected senior partners and of more junior lawyers who also attract roles in important life sciences sector cases. The firm acts for some of the world's most prominent pharmaceutical, biotechnology, medical devices and diagnostics companies on patent infringement actions against competing entities and any corresponding revocation actions. The law firm is increasingly recognised in regulatory work, licence agreements, as well as M&A in the life sciences sector.

Uría Menéndez demonstrates superb coverage of the various regulatory, commercial and intellectual property-related issues arising for companies operating in the life sciences sector. Its lawyers advise on the negotiation of collaboration agreements for the development or manufacture of drugs. The team has experience in applications for authorisation of supply contracts, and it advises on appeals against decisions made on pricing and reimbursement. It assists life sciences companies with questions relating to the legitimate use of health data. Uría Menéndez's civil litigation capabilities are showcased in advice on advertising disputes, product liability cases and patent infringement actions. The firm also possesses notable experience in cases relating to the enforcement of plant variety rights.

Vidal-Quadras & Ramon has a notable reputation for coverage of life sciences disputes. The lawyers are best known for their handling of patent litigation on behalf of generics manufacturers, often assisting with the filing of nullity claims against patent holders. The team also has experience in related cases in which innovators seek to challenge marketing authorisations granted to generics companies.

Bird & Bird has a recognised practice in patent litigation within the life sciences area. The law firm regularly advises clients in relation to patent infringements, as well as filing applications for intervention and damage claims.

In addition to its established reputation as a strong choice to handle patent litigation for pharmaceutical companies, Eversheds Sutherland attracts attention for its broader life sciences regulatory and commercial capabilities. The firm advises key clients from the biotechnology and pharmaceutical industries on matters relating to the authorisation, pricing and promotion of drugs. It assists manufacturers with securing the requisite approvals in order to sell life sciences products in the EU. The firm also defends product liability claims.

In addition to its established reputation as a strong choice to handle patent litigation for pharmaceutical companies, Eversheds Sutherland attracts attention for its broader life sciences regulatory and commercial capabilities. The firm advises key clients from the biotechnology and pharmaceutical industries on matters relating to the authorisation, pricing and promotion of drugs. It assists manufacturers with securing the requisite approvals in order to sell life sciences products in the EU. The firm also defends product liability claims.

Gómez-Acebo & Pombo has a well-regarded multidisciplinary practice offering capabilities in M&A, regulatory and contentious work in the life sciences sector. The firm regularly advises on public procurement matters, including appeals of public tender awards. It has acted for leading pharmaceutical manufacturers on the establishment of Spanish subsidiaries. The firm also has notable experience representing clients in patent litigation cases.

HOYNG ROKH MONEGIER's Madrid team forms part of a broader European IP practice that has experience in the coordination of significant life sciences sector patent disputes across multiple jurisdictions. The firm advises on patent infringement and invalidity actions brought by producers of drugs, biosimilar products and medical devices. It also acts for animal health and crop science companies.